Are β₃ -adrenoceptor gene polymorphisms relevant for urology?

Area of Science:

• Pharmacogenomics
• Urology
• Molecular Biology

Background:

• Beta-3 adrenoceptors (ARs) are a key drug target for overactive bladder (OAB).
• The human β3-AR gene exhibits common polymorphisms, notably the tryptophan (Trp) to arginine (Arg) exchange at position 64 (64Arg).

Purpose of the Study:

• To review the impact of β3-AR polymorphisms on urological diseases, particularly OAB.
• To evaluate the association between the β3-AR 64Arg variant and OAB prevalence and symptom severity.

Main Methods:

• Narrative review of existing literature.
• Analysis of studies investigating the 64Arg allele frequency in OAB patients versus controls.
• Examination of in vitro and in vivo studies on receptor function and agonist response.

Main Results:

• Inconsistent findings regarding the association between the 64Arg allele and OAB prevalence.
• Limited differences in symptom severity between 64Arg and 64Trp carriers.
• In vitro studies suggest potential hypofunctionality of the 64Arg variant, but results are not always confirmed.

Conclusions:

• Evidence suggests carriers of the 64Arg genotype may have fewer or hypofunctional β3-ARs, potentially linked to OAB.
• Observed associations are inconsistent, possibly due to insufficient statistical power.
• Larger, well-powered studies are required to definitively assess the functional impact of the 64Arg variant on β3-AR activity and OAB.